SLN
Silence Therapeutics PLC
10.60$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.0% | 99.3% | 99.8% | 100.0% | 99.2% | 99.2% | 99.2% | 99.1% | 98.7% | 56.3% | 57.5% | 59.8% | 30.7% | 15.9% | 12.9% | 11.7% | 53.1% | 72.6% | 74.7% | 87.0% | 75.3% | 82.8% | 75.9% | 81.3% | 88.9% | 89.7% | 89.9% | 86.4% | 92.5% | 90.3% | |
| 98.5% | 98.3% | 92.8% | 97.4% | 94.4% | 93.9% | 84.3% | 78.5% | 82.5% | 52.9% | 52.7% | 52.2% | 23.3% | 10.3% | 10.5% | 11.0% | 52.2% | 54.2% | 56.6% | 84.3% | 69.9% | 77.7% | 55.3% | 29.3% | 31.9% | 76.4% | 51.0% | 57.6% | 59.9% | 8.6% | |
| 98.5% | 98.3% | 92.8% | 97.4% | 94.4% | 93.9% | 84.3% | 78.5% | 82.5% | 52.9% | 52.7% | 52.2% | 23.3% | 10.3% | 10.5% | 11.0% | 52.2% | 71.3% | 73.4% | 84.3% | 69.9% | 78.3% | 68.2% | 72.7% | 43.6% | 76.4% | 66.2% | 57.6% | 72.7% | 64.8% | |
| – | – | 6.9% | – | – | 4.1% | 13.9% | 18.5% | – | 1.5% | 1.6% | 2.0% | 6.0% | 3.8% | 2.0% | 0.2% | 0.9% | 1.3% | 1.3% | 2.4% | 1.5% | 3.6% | 6.3% | 0.0% | 34.1% | 0.3% | 0.9% | 20.1% | 0.5% | 18.7% | |
| – | – | – | – | – | – | – | – | – | 0.5% | – | – | – | – | 0.1% | – | -0.9% | -1.3% | -1.3% | -2.7% | -5.4% | -4.5% | -6.3% | – | 1.7% | 0.0% | -15.3% | -19.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.5% | 2.1% | 2.4% | 1.3% | 1.3% | 2.0% | 2.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | 37.2% | 37.3% | 34.2% | 59.9% | 74.0% | 83.5% | 84.8% | 42.9% | 25.8% | 23.8% | 10.8% | 13.8% | 14.6% | 20.9% | 16.7% | 9.5% | 7.9% | 7.5% | 10.6% | 4.6% | 8.1% | |
| – | – | – | – | – | – | – | – | – | 5.1% | 4.3% | 4.0% | 5.7% | 6.7% | 2.8% | 2.9% | 3.1% | 0.9% | 0.0% | 0.0% | 0.1% | 0.1% | 0.2% | 0.1% | 0.0% | 0.0% | 0.3% | 0.4% | 0.2% | 0.2% | |
| 6.1% | 12.1% | 15.3% | 14.8% | 8.0% | 7.5% | 12.1% | 20.1% | 26.5% | 8.6% | 6.2% | 9.3% | 6.5% | 19.1% | 5.0% | 3.8% | 5.6% | 5.9% | 6.8% | 1.8% | 2.9% | 4.8% | 9.8% | 54.6% | 89.5% | 91.1% | 79.5% | 81.6% | 33.9% | 52.6% | |
| 6.1% | 12.1% | 15.3% | 14.8% | 8.0% | 7.5% | 12.1% | 20.1% | 16.1% | 7.8% | 6.2% | 9.3% | 6.5% | 19.1% | 5.0% | 3.8% | 5.6% | 5.9% | 6.8% | 1.8% | 2.9% | 4.8% | 9.8% | 20.9% | 29.7% | 15.8% | 20.4% | 18.7% | 8.3% | 10.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.0% | 4.3% | 4.9% | – | – | – | – | 0.6% | 0.4% | 0.1% | 0.4% | 0.2% | 0.1% | 0.1% | |
| 1.6% | 3.8% | 4.6% | 4.5% | 1.9% | 1.6% | 2.6% | 4.9% | 4.9% | 2.4% | 2.1% | 3.2% | 3.0% | 5.7% | 1.0% | 1.3% | 5.6% | 5.9% | 6.8% | 0.3% | 0.9% | 0.8% | 2.9% | 3.9% | 2.7% | 4.2% | 3.0% | 2.8% | 1.8% | 3.4% | |
| 93.9% | 87.9% | 84.7% | 85.2% | 92.0% | 92.5% | 87.9% | 79.9% | 73.5% | 91.4% | 93.8% | 90.7% | 93.5% | 80.9% | 95.0% | 96.2% | 94.4% | 94.1% | 93.2% | 98.2% | 97.1% | 95.2% | 90.2% | 45.4% | 10.5% | 8.9% | 20.5% | 23.3% | 66.1% | 47.4% | |
| -27.0% | -68.3% | -131.2% | -67.7% | -76.5% | -118.5% | -152.4% | -234.5% | -569.9% | -126.7% | -153.0% | -157.2% | -264.7% | -410.7% | -158.5% | -172.8% | -485.7% | -313.5% | -345.8% | -177.8% | -207.8% | -211.7% | -344.0% | -329.9% | -214.3% | -231.8% | -244.9% | -456.9% | -233.9% | -428.0% | |
| 1.9% | 2.4% | 3.3% | 1.3% | 1.3% | 1.6% | 1.9% | 2.5% | 5.6% | 2.7% | 4.3% | 4.5% | 6.3% | 9.2% | 6.1% | 9.9% | 37.4% | 50.0% | 56.5% | 34.7% | 41.7% | 42.4% | 60.3% | 54.3% | 31.7% | 30.8% | 10.0% | 13.1% | 9.5% | 12.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.